TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
HAIC of FOLFOX Plus Sorafenib vs HAIC of FOLFIRINOX Plus Sorafenib for Advcanced HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 2 Study of Sorafenib Plus HAIC of FOLFOX vs. Sorafenib Plus HAIC of OXA for Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE2
Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
- Status
- TERMINATED
- Phase
- NA
Radial Versus Femoral Access for Superselective Embolization of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- NA
Bipolar RFA Using Twin ICW Electrodes vs. Switching Monopolar RFA for Recurrent HCC
- Status
- COMPLETED
- Phase
- NA
HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC)
- Status
- COMPLETED
- Phase
- N/A
HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Sintilimab in Combination With IBI305 (Anti-VEGF Monoclonal Antibody) Compared to Sorafenib as the First-Line Treatment for Advanced Hepatocellular Carcinoma.
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
A Trial of SHR-1210 in Combination With Apatinib in Patients With Unresectable HCC
- Status
- UNKNOWN
- Phase
- PHASE2
The Application of Indocyanine-Green(ICG) Fluorescence Imaging in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE1
Lenvatinib Plus PD-1 Antibody vs TACE for Intermediate-stage HCC Beyond Up-to-seven Criteria
- Status
- WITHDRAWN
- Phase
- PHASE3
Radiofrequency Ablation Combined With Recombinant Human Adenovirus Type 5 in the Treatment of Hepatocellular Carcinoma.
- Status
- UNKNOWN
- Phase
- NA
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
- Status
- TERMINATED
- Phase
- PHASE2
NeuWave Microwave Ablation HCC China Study
- Status
- COMPLETED
- Phase
- NA
TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study Investigating the Outcomes and Safety of Atezolizumab Under Real-World Conditions in Patients Treated in Routine Clinical Practice
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2